An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples